Literature DB >> 10233681

Differential effects of anti-rat CD11b monoclonal antibodies on granulocyte adhesiveness.

B Drasković-Pavlović1, L J Van Der Laan, N Pejnović, C D Dijkstra, M Colić.   

Abstract

Four different monoclonal antibodies (mAbs) reactive with rat CD11b (ED7, ED8, OX-42 and 1B6c) have been characterized for their ability to induce homotypic aggregation of granulocytes or to modify granulocyte adhesiveness triggered by phorbol myristate acetate (PMA) or N-formyl-methionyl-leucyl-phenylalanine (fMLP). Cross-blocking experiments showed that these mAbs recognize at least three different epitopes on CD11b. OX-42 mAb recognizes an inhibitory epitope since the mAb inhibited homotypic aggregation of granulocytes and their adherence to plastic in the presence of PMA or fMLP. ED7 and ED8 induced homotypic aggregation of granulocytes which was blocked by OX-42 and anti-CD18 mAb (WT3) suggesting that CR3 itself is involved in the adhesion process. The aggregation was dependent on active cell metabolism, intact cytoskeleton, divalent cations and activation of tyrosine kinases sensitive to genistein. Staurosporine, okadaic acid and orthovanadate potentiated the aggregation. ED7 and ED8 potentiated homotypic aggregation and adhesion of granulocytes to plastic caused by fMLP, but inhibited granulocyte adhesion to plastic induced by PMA. 1B6c recognizes an epitope that transmits a proaggregatory signal upon binding of the mAb but only if the granulocytes are in contact with plastic or are activated by fMLP. In contrast, 1B6c inhibited granulocyte adhesion to plastic triggered by PMA or fMLP. These data suggest the existence of functionally different epitopes on rat CD11b and indicate that some anti-CD11b mAbs are able to functionally activate CR3.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233681      PMCID: PMC2326711          DOI: 10.1046/j.1365-2567.1999.00654.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

1.  Identification of the complement iC3b binding site in the beta 2 integrin CR3 (CD11b/CD18).

Authors:  T Ueda; P Rieu; J Brayer; M A Arnaout
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

2.  Dynamic state of beta 2 integrin phosphorylation: regulation of neutrophil aggregation involves a phosphatase-dependent pathway.

Authors:  J T Merrill; R J Winchester; J P Buyon
Journal:  Clin Immunol Immunopathol       Date:  1994-05

3.  Characterization of the rat leukocyte integrin, CD11/CD18, by the use of LFA-1 subunit-specific monoclonal antibodies.

Authors:  T Tamatani; M Kotani; M Miyasaka
Journal:  Eur J Immunol       Date:  1991-03       Impact factor: 5.532

4.  Role of beta 1, beta 2 integrins and ICAM-1 in lung injury after deposition of IgG and IgA immune complexes.

Authors:  M S Mulligan; G P Wilson; R F Todd; C W Smith; D C Anderson; J Varani; T B Issekutz; M Miyasaka; T Tamatani; M Myasaka
Journal:  J Immunol       Date:  1993-03-15       Impact factor: 5.422

5.  Cocapping of the leukoadhesin molecules complement receptor type 3 and lymphocyte function-associated antigen-1 with Fc gamma receptor III on human neutrophils. Possible role of lectin-like interactions.

Authors:  M Zhou; R F Todd; J G van de Winkel; H R Petty
Journal:  J Immunol       Date:  1993-04-01       Impact factor: 5.422

6.  Induction of homotypic T cell adhesion by triggering of leukocyte function-associated antigen-1 alpha (CD11a): differential effects on resting and activated T cells.

Authors:  G Koopman; M de Graaff; A C Huysmans; C J Meijer; S T Pals
Journal:  Eur J Immunol       Date:  1992-07       Impact factor: 5.532

7.  Antibody against the Leu-CAM beta-chain (CD18) promotes both LFA-1- and CR3-dependent adhesion events.

Authors:  M K Robinson; D Andrew; H Rosen; D Brown; S Ortlepp; P Stephens; E C Butcher
Journal:  J Immunol       Date:  1992-02-15       Impact factor: 5.422

8.  A novel anti-rat CD18 monoclonal antibody triggers lymphocyte homotypic aggregation and granulocyte adhesion to plastic: different intracellular signaling pathways in resting versus activated thymocytes.

Authors:  M D Pavlović; M Colić; N Pejnović; T Tamatani; M Miyasaka; A Dujić
Journal:  Eur J Immunol       Date:  1994-07       Impact factor: 5.532

9.  Granulocyte activation via a binding site near the C-terminal region of complement receptor type 3 alpha-chain (CD11b) potentially involved in intramembrane complex formation with glycosylphosphatidylinositol-anchored Fc gamma RIIIB (CD16) molecules.

Authors:  J Stöckl; O Majdic; W F Pickl; A Rosenkranz; E Prager; E Gschwantler; W Knapp
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

10.  ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18).

Authors:  M S Diamond; D E Staunton; A R de Fougerolles; S A Stacker; J Garcia-Aguilar; M L Hibbs; T A Springer
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

View more
  4 in total

Review 1.  Functional properties of granulocytes after thermal injury.

Authors:  Biljana Draskovic-Pavlovic; Dragana Vucevic; Biljana Bozic; Ivana Majstorovic; Miodrag Colic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

2.  Neutrophil cytoskeletal rearrangements during capillary sequestration in bacterial pneumonia in rats.

Authors:  Kazuo Yoshida; Ryoichi Kondo; Qin Wang; Claire M Doerschuk
Journal:  Am J Respir Crit Care Med       Date:  2006-06-01       Impact factor: 21.405

3.  Down-regulation of multiple low dose streptozotocin-induced diabetes by mycophenolate mofetil.

Authors:  D Maksimovic-Ivanic; V Trajkovic; D J Miljkovic; M Mostarica Stojkovic; S Stosic-Grujicic
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

4.  Small molecule agonists of integrin CD11b/CD18 do not induce global conformational changes and are significantly better than activating antibodies in reducing vascular injury.

Authors:  Mohd Hafeez Faridi; Mehmet M Altintas; Camilo Gomez; Juan Camilo Duque; Roberto I Vazquez-Padron; Vineet Gupta
Journal:  Biochim Biophys Acta       Date:  2013-02-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.